首页> 外文OA文献 >A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172

【2h】

A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172

机译：与静脉内化疗相比，III阶段阶段最佳消泡卵巢癌患者血清CA-125水平的妇科肿瘤群研究：患有GOG患者172患者的分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Thomas C. Krivak; Chunqiao Tian; G. Scott Rose; Deborah K. Armstrong; G. Larry Maxwell;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172. [J] . Krivak TC, Tian C, Rose GS Gynecologic Oncology: An International Journal . 2009,第1期

机译：妇科肿瘤学小组研究与腹腔化疗相比，经腹膜内治疗的III期最佳减灭性卵巢癌患者血清CA-125水平：对GOG 172入组患者的分析。
2. Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. [J] . Havrilesky LJ, Secord AA, Darcy KM, Journal of Clinical Oncology . 2008,第25期

机译：妇科肿瘤学小组的研究显示，腹腔内与静脉化疗相比具有最佳切除效果的III期卵巢癌女性的成本效益。
3. Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a GEICO study. [J] . Oaknin A, Roda D, Gonzalez Martin A, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2011,第6期

机译：GEICO研究显示，改良的门诊静脉/腹腔内化疗方案在最佳的晚期III期卵巢癌患者中的可行性。
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Comfort Levels of Gynecology Cancer Patients Receiving Intraperitoneal Chemotherapy: A Pilot Study. [D] . Whyte, Darlene. 2010

机译：接受腹腔化疗的妇科癌症患者的舒适度水平：一项先导研究。
6. A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172 [O] . Thomas C. Krivak, Chunqiao Tian, G. Scott Rose, -1

机译：与静脉内化疗相比III阶段阶段最佳消泡卵巢癌患者血清CA-125水平的妇科肿瘤群研究：患有GOG患者172患者的分析
7. Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study [O] . Havrilesky, Laura J., Alvarez Secord, Angeles, Darcy, Kathleen M., 2008

机译：腹膜内化疗与静脉化疗对最佳切除III期卵巢癌女性的成本效益：妇科肿瘤小组研究

A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172

著录项

引文网络

相似文献

相关主题

期刊订阅